Lumida
/MPLT
⌘K
MPLT

MPLT

MPLT
$37.87USD↑+1.75%+0.65 today

MARKET CAP

1.6B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$36 – $39

52W RANGE

$12
$40

AI Summary

Stalk
StalkMedium

The stock remains in a Stage 2 advancing regime with intact long- and medium-term uptrends, but extreme overbought conditions and recent parabolic extension signal that entry timing is poor; waiting for a pullback into rising 9/21 EMA support before engaging offers a better risk profile.

  • ↑Phase 2 IRIS trial showed significant irritability reduction, enabling FDA discussions.
  • ↑13F filings show >1.15 institutional ownership, reflecting robust investor support.
  • ↓Q1 2026 net loss widened to -$1.34 per share, exceeding forecasts.
Full analysis →
Insider Trades0 trades
No trades match the current filters